Analgesics
Antiandrogens
Antihistamines
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Metformin Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta Thermotherapy Meta
Melatonin Meta

All Studies   Meta Analysis       

Vitamin D status in children with COVID-19: does it affect the development of long COVID and its symptoms?

Perestiuk et al., Frontiers in Pediatrics, doi:10.3389/fped.2025.1507169
Feb 2025  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
PASC 54% Improvement Relative Risk Vitamin D for COVID-19  Perestiuk et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Prospective study of 162 patients in Ukraine (Sep 2022 - Mar 2024) Lower PASC with higher vitamin D levels (p=0.035) c19early.org Perestiuk et al., Frontiers in Pediatr.., Feb 2025 Favorsvitamin D Favorscontrol 0 0.5 1 1.5 2+
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020, now with p < 0.00000000001 from 125 studies, recognized in 9 countries.
No treatment is 100% effective. Protocols combine treatments.
5,300+ studies for 116 treatments. c19early.org
Prospective study of 162 hospitalized children in Ukraine showing increased risk of developing long COVID in children with vitamin D deficiency/insufficiency, especially neurological and musculoskeletal symptoms.
This is the 214th COVID-19 sufficiency study for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 4,225,339,384 vigintillion).
risk of PASC, 54.3% lower, OR 0.46, p = 0.03, high D levels 108, low D levels 54, inverted to make OR<1 favor high D levels, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Perestiuk et al., 14 Feb 2025, prospective, Ukraine, peer-reviewed, 5 authors, study period September 2022 - March 2024. Contact: perestiuk_vo@tdmu.edu.ua.
This PaperVitamin DAll
Vitamin D status in children with COVID-19: does it affect the development of long COVID and its symptoms?
Vita Perestiuk, Tetyana Kosovska, Olha Dyvoniak, Liubov Volianska, Oksana Boyarchuk
Frontiers in Pediatrics, doi:10.3389/fped.2025.1507169
Introduction: Long COVID is characterized by diverse symptoms persisting after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Given the immunomodulatory and neuroprotective properties of vitamin D, understanding its role in long COVID symptoms is of growing interest. This study aimed to determine vitamin D status in children with COVID-19 and assess its impact on the clinical course of disease and long COVID development. Methods: A prospective cohort study included hospitalized children with confirmed COVID-19, aged 1 month to 18 years, diagnosed between September 2022 and March 2024. Serum 25-hydroxyvitamin D (25(OH)D) concentrations were measured upon hospital admission, and follow-up was done to identify long COVID symptoms. Results: In total, 162 hospitalized patients with COVID-19 were examined. Vitamin D deficiency was determined in 8.0%, insufficiency in 25.3%, and optimal levels in 66.7% of children with COVID-19. Vitamin D deficiency/insufficiency was observed in 73% of children over 6 years and 21.6% of children under 6 years of age. Comorbid conditions were 1.4 times more frequent in children with vitamin D insufficiency, with undernutrition and obesity playing the most significant roles ( p = 0.0023, p = 0.0245, respectively). Serum 25(OH)D concentration depends on COVID-19 severity ( p = 0.0405) and children with vitamin D deficiency/insufficiency had a longer hospital stay (4 vs. 3 days, p = 0.0197). The vitamin D status affected the median levels of neutrophils, lymphocytes, their ratio, prothrombin time, fibrinogen levels, and the frequency of increased immunoglobulins M and E levels. Among 134 children who agreed to follow up, 56 (41.8%) experienced long COVID symptoms, while 78 (58.2%) recovered fully. Long COVID was frequently observed in children with vitamin D deficiency/insufficiency ( p = 0.0331). The odds of developing long COVID were 2.2 times higher ( p = 0.0346) in children with vitamin D deficiency/ insufficiency compared to those with optimal levels. Children with vitamin D deficiency/insufficiency more often exhibited neurological (80% vs. 41.9%, p = 0.0040) and musculoskeletal symptoms (16% vs. 0%, p = 0.0208). Conclusion: The 25(OH)D concentrations in children with COVID-19 depended on their age. Comorbid conditions affect the vitamin D status in children with COVID-19. Vitamin D influenced the COVID-19 severity and duration of hospitalization. There was an increased risk of developing long COVID in children with vitamin D deficiency/insufficiency, and its impact on the development of neurological symptoms associated with long COVID was established.
Ethics statement The studies involving humans were approved by I. Horbachevsky Ternopil National Medical University Ethics Committee. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants' legal guardians/next of kin. Author contributions Funding The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The study was financed by the Ministry of Health of Ukraine with funds from the state budget, project title "Assessment of the quality of life and psychological state of children with long COVID-19 in time of war", state registration number 0123U100301, implementation period -2023-2025. Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Generative AI statement The author(s) declare that no Generative AI was used in the creation of this manuscript. Publisher's note All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Against, -19 Post-Acute Care Study Group. Post-COVID-19 global health strategies: the need for an interdisciplinary approach, Aging Clin Exp Res, doi:10.1007/s40520-—020-—01616-—x
Ahmad, Juber, Al-Naseri, Heumann, Ali et al., Association between average vitamin D levels and COVID-19 mortality in 19 European countries-A population-based study, Nutrients, doi:10.3390/nu15224818
Akbar, Wibowo, Pranata, Setiabudiawan, Low serum 25-hydroxyvitamin D (vitamin D) level is associated with susceptibility to COVID-19, severity, and mortality: a systematic review and meta-analysis, Front Nutr, doi:10.3389/fnut.2021.660420
Alpcan, Tursun, Kandur, Vitamin D levels in children with COVID-19: a report from Turkey, Epidemiol Infect
Aribi, Mennechet, Touil-Boukoffa, Editorial: the role of vitamin D as an immunomodulator, Front Immunol, doi:10.3389/fimmu.2023.1186635
Ashkenazi-Hoffnung, Shmueli, Ehrlich, Ziv, Bar-On et al., Long COVID in children: observations from a designated pediatric clinic, Pediatr Infect Dis J, doi:10.1097/INF.0000000000003285
Bayrak, Öztürk, Bolat, Ünay, Association between vitamin D levels and COVID-19 infection in children: a case-control study, Turk Arch Pediatr, doi:10.5152/TurkArchPediatr.2023.22217
Bayramoğlu, Akkoç, Ağbaş, Akgün, Yurdakul et al., The association between vitamin D levels and the clinical severity and inflammation markers in pediatric COVID-19 patients: single-center experience from a pandemic hospital, Eur J Pediatr, doi:10.1007/s00431-—021-—04030-—1
Borch, Holm, Knudsen, Ellermann-Eriksen, Hagstroem, Long COVID symptoms and duration in SARS-CoV-2 positive children -a nationwide cohort study, Eur J Pediatr, doi:10.1007/s00431-—021-—04345-—z
Boyarchuk, Monastyrska, Suvalko, Perestiuk, Hariyan, Impact of COVID-19, pandemic, and full-scale war on the health of schoolchildren: survey results, Ukr J Perinatol Pediatr, doi:10.15574/PP.2024.98.77
Boyarchuk, Perestiuk, Kosovska, Volianska, Coagulation profile in hospitalized children with COVID-19: pediatric age dependency and its impact on long COVID development, Front Immunol, doi:10.3389/fimmu.2024.1363410
Boyarchuk, Predyk, Yuryk, COVID-19 in patients with juvenile idiopathic arthritis: frequency and severity, Reumatologia, doi:10.5114/reum.2021.107590
Boyarchuk, Volianska, Autoimmunity and long COVID in children, Reumatologia, doi:10.5114/reum/176464
Chen, Chang, Yang, Tsai, Wei et al., Neuroimmunological effect of vitamin D on neuropsychiatric long COVID syndrome: a review, Nutrients, doi:10.3390/nu15173802
Chen, Lin, Chen, Effects of vitamin D and zinc deficiency in acute and long COVID syndrome, J Trace Elem Med Biol, doi:10.1016/j.jtemb.2023.127278
Chen, Sims, Chen, Gu, Chen et al., Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation, J Immunol, doi:10.4049/jimmunol.179.3.1634
Cooper, Crofts, Dinicolantonio, Malhotra, Elliott et al., Relationships between hyperinsulinaemia, magnesium, vitamin D, thrombosis and COVID-19: rationale for clinical management, Open Heart, doi:10.1136/openhrt-2020-—001356
Cowling, Ali, Ng, Tsang, Li et al., Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study, Lancet Public Health, doi:10.1016/S2468-—2667—(20)—30090-—6
Darren, Osman, Masilamani, Ali, Kanthimathinathan et al., Vitamin D status of children with paediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus 2 (PIMS-TS), Br J Nutr, doi:10.1017/S0007114521001562
Di Filippo, Frara, Nannipieri, Cotellessa, Locatelli et al., Low vitamin D levels are associated with long COVID syndrome in COVID-19 survivors, J Clin Endocrinol Metab, doi:10.1210/clinem/dgad207
Fainardi, Meoli, Chiopris, Motta, Skenderaj et al., Long COVID in children and adolescents, World J Pediatr, doi:10.1007/s12519-—021-—00457-—6
Fernández-De-Las-Peñas, Palacios-Ceña, Gómez-Mayordomo, Rodríuez-Jiménez, Palacios-Ceña et al., Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: a multicenter study, J Infect, doi:10.1016/j.jinf.2021.04.036
Fong, Gao, Wong, Xiao, Shiu et al., Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings-social distancing measures, Emerg Infect Dis, doi:10.3201/eid2605.190995
Getachew, Landis, Manaye, Tizabi, COVID-19-associated coagulopathy: role of vitamins D and K, Curr Pharm Biotechnol, doi:10.2174/1389201023666220527110455
Gombart, The vitamin D-antimicrobial peptide pathway and its role in protection against infection, Future Microbiol, doi:10.2217/fmb.09.87
Guerrero-Romero, Gamboa-Gómez, Rodríguez-Morán, Orrante, Rosales-Galindo et al., Hypomagnesemia and 25-hydroxyvitamin D deficiency in patients with long COVID, Magnes Res, doi:10.1684/mrh.2023.0519
Hikmet, Wejse, Agergaard, Effect of vitamin D in long COVID patients, Int J Environ Res Public Health, doi:10.3390/ijerph20227058
Hussein, Galal, Amin, Moshnib, Makhlouf et al., Prevalence of vitamin D deficiency among patients attending post COVID-19 follow-up clinic: a cross-sectional study, Eur Rev Med Pharmacol Sci, doi:10.26355/eurrev_202204_28635
Iacopetta, Ceramella, Catalano, Saturnino, Pellegrino et al., COVID-19 at a glance: an up-to-date overview on variants, drug design and therapies, Viruses, doi:10.3390/v14030573
Karimian, Tahami, Sayyahfar, Delavar, Association of vitamin D and severity of COVID-19 in children, Eur J Transl Myol, doi:10.4081/ejtm.2022.10453
Kinash, Boyarchuk, Fat-soluble vitamins and immunodeficiency: mechanisms of influence and opportunities for use, Vopr Pitan, doi:10.24411/0042-—8833-—2020-—10026
Kosmeri, Balomenou, Rallis, Baltogianni, Giapros, The role of serum vitamin 25(OH)D concentration in the COVID-19 pandemic in children, Br J Nutr, doi:10.1017/S0007114522003476
Lips, Vitamin D physiology, Prog Biophys Mol Biol, doi:10.1016/j.pbiomolbio.2006.02.016
Marino, Misra, Extra-skeletal effects of vitamin D, Nutrients, doi:10.3390/nu11071460
Mizrahi, Sudry, Flaks-Manov, Yehezkelli, Kalkstein et al., Long COVID outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study, Br Med J, doi:10.1136/bmj-2022-—072529
Mosca, Colucci, Savoia, Calì, Bene et al., Vitamin D levels in the pre-and post-COVID-19 pandemic periods and related confinement at pediatric age, Nutrients, doi:10.3390/nu15092089
Mundula, Russo, Curini, Giudici, Piccioni et al., Chronic systemic low-grade inflammation and modern lifestyle: the dark role of gut microbiota on related diseases with a focus on COVID-19 pandemic, Curr Med Chem
Nalbandian, Sehgal, Gupta, Madhavan, Mcgroder et al., Postacute COVID-19 syndrome, Nat Med, doi:10.1038/s41591-—021-—01283-—z
Nicolae, Mihai, Chisnoiu, Balasa, Frecus et al., Immunomodulatory effects of vitamin D in respiratory tract infections and COVID-19 in children, Nutrients, doi:10.3390/nu15153430
Norman, From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health, Am J Clin Nutr, doi:10.1093/ajcn/88.2.491S
Nowson, Mcgrath, Ebeling, Haikerwal, Daly et al., Vitamin D and health in adults in Australia and New Zealand: a position statement, Med J Aust, doi:10.5694/mja11.10301
Osmanov, Spiridonova, Bobkova, Gamirova, Shikhaleva et al., Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC global follow-up protocol: a prospective cohort study, Eur Respir J, doi:10.1183/13993003.01341-—2021
Peraire, García-Pardo, Chafino, Sánchez, Botero-Gallego et al., Immunoglobulins in COVID-19 pneumonia: from the acute phase to the recovery phase, Eur J Med Res, doi:10.1186/s40001-—024-—01824-—5
Perlis, Green, Santillana, Lazer, Ognyanova et al., Persistence of symptoms up to 10 months following acute COVID-19 illness, medRxiv, doi:10.1101/2021.03.07.21253072
Piazza, Cicco, Pecoraro, Ghezzi, Peroni et al., Long COVID-19 in children: from the pathogenesis to the biologically plausible roots of the syndrome, Biomolecules, doi:10.3390/biom12040556
Pizzini, Aichner, Sahanic, Böhm, Egger et al., Impact of vitamin D deficiency on COVID-19-a prospective analysis from the CovILD registry, Nutrients, doi:10.3390/nu12092775
Pludowski, COVID-19 and other pleiotropic actions of vitamin D: proceedings from the fifth international conference "vitamin D-minimum, maximum, optimum" under the auspices of the European vitamin D association (EVIDAS), Nutrients, doi:10.3390/nu15112530
Rao, Lee, Razzaghi, Lorman, Mejias et al., Clinical features and burden of postacute sequelae of SARS-CoV-2 infection in children and adolescents, JAMA Pediatr, doi:10.1001/jamapediatrics.2022.2800
Salamanna, Maglio, Sartori, Landini, Fini, Vitamin D and platelets: a menacing duo in COVID-19 and potential relation to bone remodeling, Int J Mol Sci, doi:10.3390/ijms221810010
Seal, Bertenthal, Carey, Grunfeld, Bikle et al., Association of vitamin D Status and COVID-19-related hospitalization and mortality, J Gen Intern Med, doi:10.1007/s11606-—021-—07170-—0
Susianti, Wahono, Rahman, Pratama, Wulanda et al., Low levels of vitamin D were associated with coagulopathy among hospitalized coronavirus disease-19 (COVID-19) patients: a single-centered study in Indonesia, J Med Biochem, doi:10.5937/jomb0-—30228
Swann, Holden, Turtle, Pollock, Fairfield et al., Clinical characteristics of children and young people admitted to hospital with COVID-19 in United Kingdom: prospective multicentre observational cohort study, Br Med J, doi:10.1136/bmj.m3249
Szerszeń, Kucharczyk, Bojarska-Senderowicz, Pohorecka, Śliwczyński et al., Effect of vitamin D concentration on course of COVID-19, Med Sci Monit, doi:10.12659/MSM.937741
Townsend, Dyer, Mccluskey, 'brien, Dowds et al., Investigating the relationship between vitamin D and persistent symptoms following SARS-CoV-2 infection, Nutrients, doi:10.3390/nu13072430
Venkatesan, NICE guideline on long COVID, Lancet Respir Med, doi:10.1016/S2213-—2600—(21)—00031-—X
Vierucci, Pistoia, Fanos, Gori, Carlone et al., Vitamin D status and predictors of hypovitaminosis D in Italian children and adolescents: a cross-sectional study, Eur J Pediatr, doi:10.1007/s00431-—013-—2119-—z
Volianska, Burbela, Kosovska, Perestiuk, Boyarchuk, Long COVID in children: frequency and diagnostic challenges, Ukr J Perinatol Pediatr, doi:10.15574/PP.2023.95.101
Volianska, Burbela, Kosovska, Perestiuk, Boyarchuk, The role of vitamin D in the course of SARS-CoV-2 infection and long COVID in children (literature review), Child's Health, doi:10.22141/2224-—0551.18.3.2023.1590
Votto, Castagnoli, Marseglia, Licari, Brambilla, COVID-19 and autoimmune diseases: is there a connection?, Curr Opin Allergy Clin Immunol, doi:10.1097/ACI.0000000000000888
Wang, Zhang, Zhao, Zhang, Jiang, Mitigate the effects of home confinement on children during the COVID-19 outbreak, Lancet, doi:10.1016/S0140-—6736—(20)—30547-—X
Wong, Kwong, Wu, Chan, Chu et al., Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong, J Hosp Infect, doi:10.1016/j.jhin.2020.03.036
Wu, Liu, Hsu, Tsai, Liu et al., Association between vitamin D deficiency and post-acute outcomes of SARS-CoV-2 infection, Eur J Nutr, doi:10.1007/s00394-—023-—03298-—3
Yu, Ke, Luo, Guo, Wu, Effect of pandemic-related confinement on vitamin D status among children aged 0-6 years in Guangzhou, China: a cross-sectional study, Risk Manag Healthc Policy, doi:10.2147/RMHP.S282495
Zengin, Bal, Goren, Bayturan, Alkan et al., Serum vitamin D levels in relation to development of multisystem inflammatory syndrome in pediatric COVID-19, J Pediatr Infect Dis, doi:10.1055/s-0042-—1756713
Zimmermann, Pittet, Curtis, How common is long COVID in children and adolescents?, Pediatr Infect Dis J, doi:10.1097/INF.0000000000003328
DOI record: { "DOI": "10.3389/fped.2025.1507169", "ISSN": [ "2296-2360" ], "URL": "http://dx.doi.org/10.3389/fped.2025.1507169", "abstract": "<jats:sec><jats:title>Introduction</jats:title><jats:p>Long COVID is characterized by diverse symptoms persisting after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Given the immunomodulatory and neuroprotective properties of vitamin D, understanding its role in long COVID symptoms is of growing interest. This study aimed to determine vitamin D status in children with COVID-19 and assess its impact on the clinical course of disease and long COVID development.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>A prospective cohort study included hospitalized children with confirmed COVID-19, aged 1 month to 18 years, diagnosed between September 2022 and March 2024. Serum 25-hydroxyvitamin D (25(OH)D) concentrations were measured upon hospital admission, and follow-up was done to identify long COVID symptoms.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>In total, 162 hospitalized patients with COVID-19 were examined. Vitamin D deficiency was determined in 8.0%, insufficiency in 25.3%, and optimal levels in 66.7% of children with COVID-19. Vitamin D deficiency/insufficiency was observed in 73% of children over 6 years and 21.6% of children under 6 years of age. Comorbid conditions were 1.4 times more frequent in children with vitamin D insufficiency, with undernutrition and obesity playing the most significant roles (<jats:italic>p</jats:italic> = 0.0023, <jats:italic>p</jats:italic> = 0.0245, respectively). Serum 25(OH)D concentration depends on COVID-19 severity (<jats:italic>p</jats:italic> = 0.0405) and children with vitamin D deficiency/insufficiency had a longer hospital stay (4 vs. 3 days, <jats:italic>p</jats:italic> = 0.0197). The vitamin D status affected the median levels of neutrophils, lymphocytes, their ratio, prothrombin time, fibrinogen levels, and the frequency of increased immunoglobulins M and E levels. Among 134 children who agreed to follow up, 56 (41.8%) experienced long COVID symptoms, while 78 (58.2%) recovered fully. Long COVID was frequently observed in children with vitamin D deficiency/insufficiency (<jats:italic>p</jats:italic> = 0.0331). The odds of developing long COVID were 2.2 times higher (<jats:italic>p</jats:italic> = 0.0346) in children with vitamin D deficiency/insufficiency compared to those with optimal levels. Children with vitamin D deficiency/insufficiency more often exhibited neurological (80% vs. 41.9%, <jats:italic>p</jats:italic> = 0.0040) and musculoskeletal symptoms (16% vs. 0%, <jats:italic>p</jats:italic> = 0.0208).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>The 25(OH)D concentrations in children with COVID-19 depended on their age. Comorbid conditions affect the vitamin D status in children with COVID-19. Vitamin D influenced the COVID-19 severity and duration of hospitalization. There was an increased risk of developing long COVID in children with vitamin D deficiency/insufficiency, and its impact on the development of neurological symptoms associated with long COVID was established.</jats:p></jats:sec>", "alternative-id": [ "10.3389/fped.2025.1507169" ], "author": [ { "affiliation": [], "family": "Perestiuk", "given": "Vita", "sequence": "first" }, { "affiliation": [], "family": "Kosovska", "given": "Tetyana", "sequence": "additional" }, { "affiliation": [], "family": "Dyvoniak", "given": "Olha", "sequence": "additional" }, { "affiliation": [], "family": "Volianska", "given": "Liubov", "sequence": "additional" }, { "affiliation": [], "family": "Boyarchuk", "given": "Oksana", "sequence": "additional" } ], "container-title": "Frontiers in Pediatrics", "container-title-short": "Front. Pediatr.", "content-domain": { "crossmark-restriction": true, "domain": [ "frontiersin.org" ] }, "created": { "date-parts": [ [ 2025, 2, 19 ] ], "date-time": "2025-02-19T12:46:51Z", "timestamp": 1739969211000 }, "deposited": { "date-parts": [ [ 2025, 2, 19 ] ], "date-time": "2025-02-19T12:46:56Z", "timestamp": 1739969216000 }, "indexed": { "date-parts": [ [ 2025, 2, 19 ] ], "date-time": "2025-02-19T13:10:31Z", "timestamp": 1739970631011, "version": "3.37.3" }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2025, 2, 14 ] ] }, "license": [ { "URL": "https://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 2, 14 ] ], "date-time": "2025-02-14T00:00:00Z", "timestamp": 1739491200000 } } ], "link": [ { "URL": "https://www.frontiersin.org/articles/10.3389/fped.2025.1507169/full", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "1965", "original-title": [], "prefix": "10.3389", "published": { "date-parts": [ [ 2025, 2, 14 ] ] }, "published-online": { "date-parts": [ [ 2025, 2, 14 ] ] }, "publisher": "Frontiers Media SA", "reference": [ { "DOI": "10.1007/s40520-020-01616-x", "article-title": "Post-COVID-19 global health strategies: the need for an interdisciplinary approach", "doi-asserted-by": "publisher", "first-page": "1613", "journal-title": "Aging Clin Exp Res", "key": "B1", "volume": "32", "year": "2020" }, { "DOI": "10.1136/bmj.m3249", "article-title": "Clinical characteristics of children and young people admitted to hospital with COVID-19 in United Kingdom: prospective multicentre observational cohort study", "author": "Swann", "doi-asserted-by": "publisher", "first-page": "m3249", "journal-title": "Br Med J", "key": "B2", "volume": "370", "year": "2020" }, { "DOI": "10.5114/reum.2021.107590", "article-title": "COVID-19 in patients with juvenile idiopathic arthritis: frequency and severity", "author": "Boyarchuk", "doi-asserted-by": "publisher", "first-page": "197", "journal-title": "Reumatologia", "key": "B3", "volume": "59", "year": "2021" }, { "DOI": "10.1007/s00431-021-04345-z", "article-title": "Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study", "author": "Borch", "doi-asserted-by": "publisher", "first-page": "1597", "journal-title": "Eur J Pediatr", "key": "B4", "volume": "181", "year": "2022" }, { "DOI": "10.1097/INF.0000000000003328", "article-title": "How common is long COVID in children and adolescents?", "author": "Zimmermann", "doi-asserted-by": "publisher", "first-page": "e482", "journal-title": "Pediatr Infect Dis J", "key": "B5", "volume": "40", "year": "2021" }, { "key": "B6", "volume-title": "COVID-19 Dashboard", "year": "2024" }, { "key": "B7", "volume-title": "Post COVID-19 Condition (Long COVID)", "year": "2023" }, { "DOI": "10.1038/s41591-021-01283-z", "article-title": "Post-acute COVID-19 syndrome", "author": "Nalbandian", "doi-asserted-by": "publisher", "first-page": "601", "journal-title": "Nat Med", "key": "B8", "volume": "27", "year": "2021" }, { "DOI": "10.1016/S2213-2600(21)00031-X", "article-title": "NICE guideline on long COVID", "author": "Venkatesan", "doi-asserted-by": "publisher", "first-page": "129", "journal-title": "Lancet Respir Med", "key": "B9", "volume": "9", "year": "2021" }, { "DOI": "10.1097/INF.0000000000003285", "article-title": "Long COVID in children: observations from a designated pediatric clinic", "author": "Ashkenazi-Hoffnung", "doi-asserted-by": "publisher", "first-page": "e509", "journal-title": "Pediatr Infect Dis J", "key": "B10", "volume": "40", "year": "2021" }, { "DOI": "10.1136/bmj-2022-072529", "article-title": "Long COVID outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study", "author": "Mizrahi", "doi-asserted-by": "publisher", "first-page": "e072529", "journal-title": "Br Med J", "key": "B11", "volume": "380", "year": "2023" }, { "DOI": "10.15574/PP.2023.95.101", "article-title": "Long COVID in children: frequency and diagnostic challenges", "author": "Volianska", "doi-asserted-by": "publisher", "first-page": "101", "journal-title": "Ukr J Perinatol Pediatr", "key": "B12", "volume": "3", "year": "2023" }, { "DOI": "10.5114/reum/176464", "article-title": "Autoimmunity and long COVID in children", "author": "Boyarchuk", "doi-asserted-by": "publisher", "first-page": "492", "journal-title": "Reumatologia", "key": "B13", "volume": "61", "year": "2023" }, { "DOI": "10.3390/biom12040556", "article-title": "Long COVID-19 in children: from the pathogenesis to the biologically plausible roots of the syndrome", "author": "Piazza", "doi-asserted-by": "publisher", "first-page": "556", "journal-title": "Biomolecules", "key": "B14", "volume": "12", "year": "2022" }, { "DOI": "10.1007/s12519-021-00457-6", "article-title": "Long COVID in children and adolescents", "author": "Fainardi", "doi-asserted-by": "publisher", "first-page": "495", "journal-title": "World J Pediatr", "key": "B15", "volume": "17", "year": "2021" }, { "DOI": "10.1183/13993003.01341-2021", "article-title": "Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC global follow-up protocol: a prospective cohort study", "author": "Osmanov", "doi-asserted-by": "publisher", "first-page": "2101341", "journal-title": "Eur Respir J", "key": "B16", "volume": "59", "year": "2022" }, { "DOI": "10.3201/eid2605.190995", "article-title": "Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings—social distancing measures", "author": "Fong", "doi-asserted-by": "publisher", "first-page": "976", "journal-title": "Emerg Infect Dis", "key": "B17", "volume": "26", "year": "2020" }, { "DOI": "10.1016/j.jhin.2020.03.036", "article-title": "Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong", "author": "Wong", "doi-asserted-by": "publisher", "first-page": "119", "journal-title": "J Hosp Infect", "key": "B18", "volume": "105", "year": "2020" }, { "DOI": "10.1016/S2468-2667(20)30090-6", "article-title": "Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study", "author": "Cowling", "doi-asserted-by": "publisher", "first-page": "e279", "journal-title": "Lancet Public Health", "key": "B19", "volume": "5", "year": "2020" }, { "DOI": "10.1016/S0140-6736(20)30547-X", "article-title": "Mitigate the effects of home confinement on children during the COVID-19 outbreak", "author": "Wang", "doi-asserted-by": "publisher", "first-page": "945", "journal-title": "Lancet", "key": "B20", "volume": "395", "year": "2020" }, { "DOI": "10.5694/mja11.10301", "article-title": "Vitamin D and health in adults in Australia and New Zealand: a position statement", "author": "Nowson", "doi-asserted-by": "publisher", "first-page": "686", "journal-title": "Med J Aust", "key": "B21", "volume": "196", "year": "2012" }, { "DOI": "10.2147/RMHP.S282495", "article-title": "Effect of pandemic-related confinement on vitamin D status among children aged 0–6 years in Guangzhou, China: a cross-sectional study", "author": "Yu", "doi-asserted-by": "publisher", "first-page": "2669", "journal-title": "Risk Manag Healthc Policy", "key": "B22", "volume": "13", "year": "2020" }, { "DOI": "10.1093/ajcn/88.2.491S", "article-title": "From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health", "author": "Norman", "doi-asserted-by": "publisher", "first-page": "491S", "journal-title": "Am J Clin Nutr", "key": "B23", "volume": "88", "year": "2008" }, { "DOI": "10.1016/j.pbiomolbio.2006.02.016", "article-title": "Vitamin D physiology", "author": "Lips", "doi-asserted-by": "publisher", "first-page": "4", "journal-title": "Prog Biophys Mol Biol", "key": "B24", "volume": "92", "year": "2006" }, { "DOI": "10.2217/fmb.09.87", "article-title": "The vitamin D-antimicrobial peptide pathway and its role in protection against infection", "author": "Gombart", "doi-asserted-by": "publisher", "first-page": "1151", "journal-title": "Future Microbiol", "key": "B25", "volume": "4", "year": "2009" }, { "DOI": "10.3389/fimmu.2023.1186635", "article-title": "Editorial: the role of vitamin D as an immunomodulator", "author": "Aribi", "doi-asserted-by": "publisher", "first-page": "1186635", "journal-title": "Front Immunol", "key": "B26", "volume": "14", "year": "2023" }, { "DOI": "10.3390/nu11071460", "article-title": "Extra-skeletal effects of vitamin D", "author": "Marino", "doi-asserted-by": "publisher", "first-page": "1460", "journal-title": "Nutrients", "key": "B27", "volume": "11", "year": "2019" }, { "DOI": "10.3390/v14030573", "article-title": "COVID-19 at a glance: an up-to-date overview on variants, drug design and therapies", "author": "Iacopetta", "doi-asserted-by": "publisher", "first-page": "573", "journal-title": "Viruses", "key": "B28", "volume": "14", "year": "2022" }, { "DOI": "10.1007/s00431-021-04030-1", "article-title": "The association between vitamin D levels and the clinical severity and inflammation markers in pediatric COVID-19 patients: single-center experience from a pandemic hospital", "author": "Bayramoğlu", "doi-asserted-by": "publisher", "first-page": "2699", "journal-title": "Eur J Pediatr", "key": "B29", "volume": "180", "year": "2021" }, { "DOI": "10.12659/MSM.937741", "article-title": "Effect of vitamin D concentration on course of COVID-19", "author": "Szerszeń", "doi-asserted-by": "publisher", "first-page": "e937741", "journal-title": "Med Sci Monit", "key": "B30", "volume": "28", "year": "2022" }, { "DOI": "10.1017/S0007114521001562", "article-title": "Vitamin D status of children with paediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus 2 (PIMS-TS)", "author": "Darren", "doi-asserted-by": "publisher", "first-page": "896", "journal-title": "Br J Nutr", "key": "B31", "volume": "127", "year": "2022" }, { "key": "B32", "volume-title": "Clinical Management of COVID-19: Interim Guidance, 27 May 2020", "year": "2020" }, { "DOI": "10.3390/nu15112530", "article-title": "COVID-19 and other pleiotropic actions of vitamin D: proceedings from the fifth international conference “vitamin D—minimum, maximum, optimum” under the auspices of the European vitamin D association (EVIDAS)", "author": "Pludowski", "doi-asserted-by": "publisher", "first-page": "2530", "journal-title": "Nutrients", "key": "B33", "volume": "15", "year": "2023" }, { "DOI": "10.5152/TurkArchPediatr.2023.22217", "article-title": "Association between vitamin D levels and COVID-19 infection in children: a case-control study", "author": "Bayrak", "doi-asserted-by": "publisher", "first-page": "250", "journal-title": "Turk Arch Pediatr", "key": "B34", "volume": "58", "year": "2023" }, { "DOI": "10.4081/ejtm.2022.10453", "article-title": "Association of vitamin D and severity of COVID-19 in children", "author": "Karimian", "doi-asserted-by": "publisher", "first-page": "10453", "journal-title": "Eur J Transl Myol", "key": "B35", "volume": "32", "year": "2022" }, { "DOI": "10.24411/0042-8833-2020-10026", "article-title": "Fat-soluble vitamins and immunodeficiency: mechanisms of influence and opportunities for use", "author": "Kinash", "doi-asserted-by": "publisher", "first-page": "22", "journal-title": "Vopr Pitan", "key": "B36", "volume": "89", "year": "2020" }, { "DOI": "10.1007/s00431-013-2119-z", "article-title": "Vitamin D status and predictors of hypovitaminosis D in Italian children and adolescents: a cross-sectional study", "author": "Vierucci", "doi-asserted-by": "publisher", "first-page": "1607", "journal-title": "Eur J Pediatr", "key": "B37", "volume": "172", "year": "2013" }, { "DOI": "10.22141/2224-0551.18.3.2023.1590", "article-title": "The role of vitamin D in the course of SARS-CoV-2 infection and long COVID in children (literature review)", "author": "Volianska", "doi-asserted-by": "publisher", "first-page": "225", "journal-title": "Child's Health", "key": "B38", "volume": "18", "year": "2023" }, { "DOI": "10.15574/PP.2024.98.77", "article-title": "Impact of COVID-19, pandemic, and full-scale war on the health of schoolchildren: survey results", "author": "Boyarchuk", "doi-asserted-by": "publisher", "first-page": "77", "journal-title": "Ukr J Perinatol Pediatr", "key": "B39", "volume": "2", "year": "2024" }, { "DOI": "10.3390/nu15092089", "article-title": "Vitamin D levels in the pre- and post-COVID-19 pandemic periods and related confinement at pediatric age", "author": "Mosca", "doi-asserted-by": "publisher", "first-page": "2089", "journal-title": "Nutrients", "key": "B40", "volume": "15", "year": "2023" }, { "DOI": "10.1017/S0950268821001825", "article-title": "Vitamin D levels in children with COVID-19: a report from Turkey", "author": "Alpcan", "doi-asserted-by": "publisher", "first-page": "e180", "journal-title": "Epidemiol Infect", "key": "B41", "volume": "149", "year": "2021" }, { "DOI": "10.3390/nu15153430", "article-title": "Immunomodulatory effects of vitamin D in respiratory tract infections and COVID-19 in children", "author": "Nicolae", "doi-asserted-by": "publisher", "first-page": "3430", "journal-title": "Nutrients", "key": "B42", "volume": "15", "year": "2023" }, { "DOI": "10.1017/S0007114522003476", "article-title": "The role of serum vitamin 25(OH)D concentration in the COVID-19 pandemic in children", "author": "Kosmeri", "doi-asserted-by": "publisher", "first-page": "417", "journal-title": "Br J Nutr", "key": "B43", "volume": "130", "year": "2023" }, { "DOI": "10.3390/nu15224818", "article-title": "Association between average vitamin D levels and COVID-19 mortality in 19 European countries-A population-based study", "author": "Ahmad", "doi-asserted-by": "publisher", "first-page": "4818", "journal-title": "Nutrients", "key": "B44", "volume": "15", "year": "2023" }, { "DOI": "10.1007/s11606-021-07170-0", "article-title": "Association of vitamin D Status and COVID-19-related hospitalization and mortality", "author": "Seal", "doi-asserted-by": "publisher", "first-page": "853", "journal-title": "J Gen Intern Med", "key": "B45", "volume": "37", "year": "2022" }, { "DOI": "10.3389/fnut.2021.660420", "article-title": "Low serum 25-hydroxyvitamin D (vitamin D) level is associated with susceptibility to COVID-19, severity, and mortality: a systematic review and meta-analysis", "author": "Akbar", "doi-asserted-by": "publisher", "first-page": "660420", "journal-title": "Front Nutr", "key": "B46", "volume": "8", "year": "2021" }, { "DOI": "10.5937/jomb0-30228", "article-title": "Low levels of vitamin D were associated with coagulopathy among hospitalized coronavirus disease-19 (COVID-19) patients: a single-centered study in Indonesia", "author": "Susianti", "doi-asserted-by": "publisher", "first-page": "341", "journal-title": "J Med Biochem", "key": "B47", "volume": "40", "year": "2021" }, { "DOI": "10.3389/fimmu.2024.1363410", "article-title": "Coagulation profile in hospitalized children with COVID-19: pediatric age dependency and its impact on long COVID development", "author": "Boyarchuk", "doi-asserted-by": "publisher", "first-page": "1363410", "journal-title": "Front Immunol", "key": "B48", "volume": "15", "year": "2024" }, { "DOI": "10.3390/ijms221810010", "article-title": "Vitamin D and platelets: a menacing duo in COVID-19 and potential relation to bone remodeling", "author": "Salamanna", "doi-asserted-by": "publisher", "first-page": "10010", "journal-title": "Int J Mol Sci", "key": "B49", "volume": "22", "year": "2021" }, { "DOI": "10.1136/openhrt-2020-001356", "article-title": "Relationships between hyperinsulinaemia, magnesium, vitamin D, thrombosis and COVID-19: rationale for clinical management", "author": "Cooper", "doi-asserted-by": "publisher", "first-page": "e001356", "journal-title": "Open Heart", "key": "B50", "volume": "7", "year": "2020" }, { "DOI": "10.2174/1389201023666220527110455", "article-title": "COVID-19-associated coagulopathy: role of vitamins D and K", "author": "Getachew", "doi-asserted-by": "publisher", "first-page": "401", "journal-title": "Curr Pharm Biotechnol", "key": "B51", "volume": "24", "year": "2023" }, { "DOI": "10.4049/jimmunol.179.3.1634", "article-title": "Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation", "author": "Chen", "doi-asserted-by": "publisher", "first-page": "1634", "journal-title": "J Immunol", "key": "B52", "volume": "179", "year": "2007" }, { "DOI": "10.1186/s40001-024-01824-5", "article-title": "Immunoglobulins in COVID-19 pneumonia: from the acute phase to the recovery phase", "author": "Peraire", "doi-asserted-by": "publisher", "first-page": "223", "journal-title": "Eur J Med Res", "key": "B53", "volume": "29", "year": "2024" }, { "DOI": "10.1097/ACI.0000000000000888", "article-title": "COVID-19 and autoimmune diseases: is there a connection?", "author": "Votto", "doi-asserted-by": "publisher", "first-page": "185", "journal-title": "Curr Opin Allergy Clin Immunol", "key": "B54", "volume": "23", "year": "2023" }, { "DOI": "10.1101/2021.03.07.21253072", "article-title": "Persistence of symptoms up to 10 months following acute COVID-19 illness", "author": "Perlis", "doi-asserted-by": "publisher", "first-page": "2021.03.07.21253072", "journal-title": "medRxiv [preprint]", "key": "B55", "volume": "3", "year": "2021" }, { "DOI": "10.1016/j.jinf.2021.04.036", "article-title": "Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: a multicenter study", "author": "Fernández-de-Las-Peñas", "doi-asserted-by": "publisher", "first-page": "237", "journal-title": "J Infect", "key": "B56", "volume": "83", "year": "2021" }, { "DOI": "10.1001/jamapediatrics.2022.2800", "article-title": "Clinical features and burden of postacute sequelae of SARS-CoV-2 infection in children and adolescents", "author": "Rao", "doi-asserted-by": "publisher", "first-page": "1000", "journal-title": "JAMA Pediatr", "key": "B57", "volume": "176", "year": "2022" }, { "DOI": "10.1210/clinem/dgad207", "article-title": "Low vitamin D levels are associated with long COVID syndrome in COVID-19 survivors", "author": "di Filippo", "doi-asserted-by": "publisher", "first-page": "e1106", "journal-title": "J Clin Endocrinol Metab", "key": "B58", "volume": "108", "year": "2023" }, { "DOI": "10.26355/eurrev_202204_28635", "article-title": "Prevalence of vitamin D deficiency among patients attending post COVID-19 follow-up clinic: a cross-sectional study", "author": "Mohamed Hussein", "doi-asserted-by": "publisher", "first-page": "3038", "journal-title": "Eur Rev Med Pharmacol Sci", "key": "B59", "volume": "26", "year": "2022" }, { "DOI": "10.1016/j.jtemb.2023.127278", "article-title": "Effects of vitamin D and zinc deficiency in acute and long COVID syndrome", "author": "Chen", "doi-asserted-by": "publisher", "first-page": "127278", "journal-title": "J Trace Elem Med Biol", "key": "B60", "volume": "80", "year": "2023" }, { "DOI": "10.1684/mrh.2023.0519", "article-title": "Hypomagnesemia and 25-hydroxyvitamin D deficiency in patients with long COVID", "author": "Guerrero-Romero", "doi-asserted-by": "publisher", "first-page": "30", "journal-title": "Magnes Res", "key": "B61", "volume": "36", "year": "2023" }, { "DOI": "10.3390/ijerph20227058", "article-title": "Effect of vitamin D in long COVID patients", "author": "Hikmet", "doi-asserted-by": "publisher", "first-page": "7058", "journal-title": "Int J Environ Res Public Health", "key": "B62", "volume": "20", "year": "2023" }, { "DOI": "10.1007/s00394-023-03298-3", "article-title": "Association between vitamin D deficiency and post-acute outcomes of SARS-CoV-2 infection", "author": "Wu", "doi-asserted-by": "publisher", "first-page": "613", "journal-title": "Eur J Nutr", "key": "B63", "volume": "63", "year": "2024" }, { "DOI": "10.3390/nu12092775", "article-title": "Impact of vitamin D deficiency on COVID-19—a prospective analysis from the CovILD registry", "author": "Pizzini", "doi-asserted-by": "publisher", "first-page": "2775", "journal-title": "Nutrients", "key": "B64", "volume": "12", "year": "2020" }, { "DOI": "10.1055/s-0042-1756713", "article-title": "Serum vitamin D levels in relation to development of multisystem inflammatory syndrome in pediatric COVID-19", "author": "Zengin", "doi-asserted-by": "publisher", "first-page": "308", "journal-title": "J Pediatr Infect Dis", "key": "B65", "volume": "17", "year": "2022" }, { "DOI": "10.3390/nu13072430", "article-title": "Investigating the relationship between vitamin D and persistent symptoms following SARS-CoV-2 infection", "author": "Townsend", "doi-asserted-by": "publisher", "first-page": "2430", "journal-title": "Nutrients", "key": "B66", "volume": "13", "year": "2021" }, { "DOI": "10.3390/nu15173802", "article-title": "Neuroimmunological effect of vitamin D on neuropsychiatric long COVID syndrome: a review", "author": "Chen", "doi-asserted-by": "publisher", "first-page": "3802", "journal-title": "Nutrients", "key": "B67", "volume": "15", "year": "2023" }, { "DOI": "10.2174/0929867329666220430131018", "article-title": "Chronic systemic low-grade inflammation and modern lifestyle: the dark role of gut microbiota on related diseases with a focus on COVID-19 pandemic", "author": "Mundula", "doi-asserted-by": "publisher", "first-page": "5370", "journal-title": "Curr Med Chem", "key": "B68", "volume": "29", "year": "2022" } ], "reference-count": 68, "references-count": 68, "relation": {}, "resource": { "primary": { "URL": "https://www.frontiersin.org/articles/10.3389/fped.2025.1507169/full" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Vitamin D status in children with COVID-19: does it affect the development of long COVID and its symptoms?", "type": "journal-article", "update-policy": "https://doi.org/10.3389/crossmark-policy", "volume": "13" }
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit